Staffing Constraints Dent Amedisys Hospice Segment; MA, JVs Expected to Spur Growth
Hospice News
OCTOBER 27, 2022
Labor shortages reduced clinical capacity for Amedisys (NASDAQ: AMED) during the summer months, which slowed hospice admissions growth during the third quarter. As staffing got tighter on our clinical side, it started to impact hospice,” CEO Chris Gerard said in a Q3 earnings call. “It The company’s hospice segment brought in $198.7
180 
Let's personalize your content